Evidence for a Role of NTS2 Receptors in the Modulation of Tonic Pain Sensitivity
Authors:
- Geneviève RoussyGRGeneviève Roussy
- Marc-André DansereauMDMarc-André Dansereau
- Stéphanie BaudissonSBStéphanie Baudisson
- Faouzi EzzoubaaFEFaouzi Ezzoubaa
- Karine BellevilleKBKarine Belleville
- Nicolas BeaudetNBNicolas Beaudet
- Jean MartinezJMJean Martinez
- Elliott RichelsonERElliott Richelson
- Philippe SarretPSPhilippe Sarret
Open Access
- 1 January 2009
- journal article
- Published by SAGE Publications in Molecular Pain
- Vol. 5 (1) , 38
Abstract
Background: Central neurotensin (NT) administration results in a naloxone-insensitive antinociceptive response in animal models of acute and persistent pain. Both NTS1 and NTS2 receptors were shown to be required for different aspects of NT-induced analgesia. We recently demonstrated that NTS2 receptors were extensively associated with ascending nociceptive pathways, both at the level of the dorsal root ganglia and of the spinal dorsal horn. Then, we found that spinally administered NTS2-selective agonists induced dose-dependent antinociceptive responses in the acute tail-flick test. In the present study, we therefore investigated whether activation of spinal NTS2 receptors suppressed the persistent inflammatory pain symptoms observed after intraplantar injection of formalin.Results: We first demonstrated that spinally administered NT and NT69L agonists, which bind to both NTS1 and NTS2 receptors, significantly reduced pain-evoked responses during the inflammatory phase of the formalin test. Accordingly, pretreatment with the NTS2-selective analogs JMV-431 and levocabastine was effective in inhibiting the aversive behaviors induced by formalin. With resolution at the single-cell level, we also found that activation of spinal NTS2 receptors reduced formalin-induced c-fos expression in dorsal horn neurons. However, our results also suggest that NTS2-selective agonists and NTS1/NTS2 mixed compounds differently modulated the early (21–39 min) and late (40–60 min) tonic phase 2 and recruited endogenous pain inhibitory mechanisms integrated at different levels of the central nervous system. Indeed, while non-selective drugs suppressed pain-related behaviors activity in both part of phase 2, intrathecal injection of NTS2-selective agonists was only efficient in reducing pain during the late phase 2. Furthermore, assessment of the stereotypic pain behaviors of lifting, shaking, licking and biting to formalin also revealed that unlike non-discriminative NTS1/NTS2 analogs reversing all nociceptive endpoint behaviors, pure NTS2 agonists specifically inhibited paw lifting, supporting a role of NTS2 in spinal modulation of persistent nociception.Conclusion: The present study provides the first demonstration that activation of NTS2 receptors produces analgesia in the persistent inflammatory pain model of formalin. The dichotomy between these two classes of compounds also indicates that both NTS1 and NTS2 receptors are involved in tonic pain inhibition and implies that these two NT receptors modulate the pain-induced behavioral responses by acting on distinct spinal and/or supraspinal neural circuits. In conclusion, development of NT agonists targeting both NTS1 and NTS2 receptors could be useful for chronic pain management.Keywords
This publication has 83 references indexed in Scilit:
- Spinal antinociceptive action of loperamide is mediated by opioid receptors in the formalin test in ratsNeuroscience Letters, 2008
- Central Delivery of Dicer-substrate siRNA: A Direct Application for Pain ResearchMolecular Therapy, 2008
- Chronic pain may change the structure of the brainPain, 2008
- Neurotensin-produced antinociception in the rostral ventromedial medulla is partially mediated by spinal cord norepinephrinePain, 2008
- Le récepteur NTS2 : un frein à la douleurmédecine/sciences, 2007
- Antinociception induced by β-lactotensin, a neurotensin agonist peptide derived from β-lactoglobulin, is mediated by NT2 and D1 receptorsLife Sciences, 2003
- Sortilin/neurotensin receptor-3: a new tool to investigate neurotensin signaling and cellular trafficking?Cellular Signalling, 2001
- Cellular distribution of neurotensin receptors in rat brain: Immunohistochemical study using an antipeptide antibody against the cloned high affinity receptorJournal of Comparative Neurology, 1996
- The formalin test: a validation of the weighted-scores method of behavioural pain ratingPain, 1993
- Apparent lack of tolerance in the formalin test suggests different mechanisms for morphine analgesia in different types of painPharmacology Biochemistry and Behavior, 1981